1. 413PClinical benefits of later line trabectedin and eribulin treatment for soft tissue sarcoma (STS) after pazopanib treatment from the Nishinomiya Sarcoma Cohort Study (NSCS). (25th November 2018) Authors: Narahara, H; Morimoto, M; Tanaka, E; Ueda, S; Yasunaga, Y; Inui, Y; Takahashi, K; Kawata, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗